跳至主要内容
临床试验/NCT04022109
NCT04022109招募中不适用

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

University of Latvia5 个研究点 分布在 5 个国家目标入组 5,000 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
5,000
试验地点
5
主要终点
Characteristic VOC pattern identification for gastric cancer detection

研究概览

简要总结

The study is aimed to determine the potential of volatile marker testing for gastric cancer screening.

The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.

详细描述

Patients with established disease (gastric cancer, precancerous lesions) as well as patients investigated for the lesions and having been documented lack of the lesions will be enrolled to the study at clinical sites in Europe (Latvia, Ukraine) and Latin America (Colombia, Chile, Brazil). In addition, group of persons from general population at average risk for developing the target disease and individuals being referred for upper endoscopy according to clinical indications will be also enrolled.

Testing of volatile markers will be conducted by one of two methods: 1) gas chromatography coupled to mass spectroscopy (GS-MS) and 2) sensor technology. Various sensors will be used and evaluated for the purpose.

The potential sources of volatile organic compounds (VOCs) in the breath will be addressed by studying VOC emission by using headspace analysis from cancer tissue, gastric contents, cancer cell cultures and H.pylori.

The potential role of gastric and faecal microbiota in the origin of VOCs in the breath will be addressed. Metabolome in the circulation will also get correlated to VOCs in the breath and with microbiome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with verified gastric cancer (Group 1 & 2)
  • Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 & 5)
  • Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4)
  • Motivation to participate in the study
  • Physical status allowing volatile marker sampling and other procedures within the protocol
  • Signed consent

排除标准

  • Known other active cancer
  • Ventilation problems, airway obstruction
  • Unwillingness or inability to co-operate

结局指标

主要结局

Characteristic VOC pattern identification for gastric cancer detection

时间窗: 2 years following initiation of patient recruitment

The characteristic VOC pattern based on sensor analysis and its performance indicators will be detected

Specific chemistry identification in the exhaled breath

时间窗: 2 years following initiation of patient recruitment

Identification of specific chemistries (GC-MS analysis) originating from gastric cancer

次要结局

  • Identification of the best-performing sensors(3 years following initiation of patient recruitment)
  • Characteristic VOC pattern identification for gastric precancerous lesion detection(2.5 years following initiation of patient recruitment)
  • Gut microbiota analysis in relation to breath VOCs(3 years following initiation of patient recruitment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marcis Leja

Director, Institute of Clinical and Preventive Medicine

University of Latvia

研究点 (5)

Loading locations...

相似试验